Navigation Links
Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
Date:7/24/2009

MUMBAI, July 24 /PRNewswire/ --

- Frost & Sullivan's Food & Beverage Focus 2009 Annual Executive MindXchange on Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector

The Indian food processing industry has seen some spectacular product developments such as probiotic fortified yoghurt, buttermilk, omega fortified health drinks and baby foods. A lot more has to be achieved through cutting edge R&D in the field of biotechnology resulting in innovative food and beverage products with improved functional and health benefits.

Production of polyunsaturated fatty acids (PUFA), probiotics, and enzymes are some of the key commercialized biotechnology applications in India. In India, consumer awareness about these new age functional ingredients and their health benefits is still low: a key challenge for this industry. Additionally, lack of defined regulations regarding usage of such products or guidelines on health claims in India is a growth restraining factor.

According to a Frost & Sullivan study, key PUFA's used in food and beverage (F&B) are Omega-3 and Omega-6 fatty acids; however, in India the focus and marketing effort is towards promoting Omega-3 in foods compared to Omega-6: the Indian diet generally contains 5 to 20 times more Omega-6 than Omega-3 PUFA's. Globally, the US is the largest manufacturer as well as the largest end-user market for PUFA followed by Asia and Europe. The total Indian market revenues for Omega-3 PUFA for food and dietary supplement applications were an estimated INR 40 Crore. Supplement applications command the major market share with over 87 percent of PUFA being used in dietary supplements whereas F&B comprises the rest 13 percent.

In food, probiotics have for long been used in the global market; this is a moderately new concept in India. Commonly dairy foods have been fortified with probiotic strains in India such as Dahi / Yoghurt, Lassi and Ice cream. Dietary supplement is the key end-user segment in India where probiotics are used in conjunction with other vitamins and minerals. Probiotics finds usage in animal feed as well as a supplement for poultry and aquaculture feeds. The total Indian market for probiotic ingredients was valued at an estimated INR 45 Crore as of 2006. Globally, Asia and Europe are the largest producers of probiotics with Europe having a bigger share of the market.

Modern biotechnology offers clear advantages over the conventional mode of production. In a sense, the ability to tailor microbial enzymes to human benefit is what makes this technology so powerful. The total Indian F&B enzymes market was worth INR 88 Crore in 2008. The market grew at 11 percent from 2007 to 2008. The market, which saw an increasing trend from 2006 growing at almost 12 percent, was interrupted by the global economic slowdown in 2007-2008. The end-user industry has not seen a major impact due to the recession. The United States, European Union, and Japan together account for more than 90 percent of the global enzyme market. Some of the countries in Asia such as China, South Korea, India, and Taiwan are expected to offer good growth opportunities.

According to Mamta Wadhwa, Sr. Director, CMF Practice, Frost & Sullivan, South Asia & Middle East, "The market has good scope of growth considering the positive growth of the Indian food processing industry in terms of new investments, new product development. This coupled with growing awareness amongst consumers about product developments in the global market is sure to drive growth in such fermentation-based food ingredients market in the long term."

The CMF Practice of Frost & Sullivan, the global growth partnership company, in its efforts to address issues on the biotechnology application market faced by Indian companies, organized an Executive MindXchange titled "Food & Beverage Focus 2009" on 24th July, which gave a special insight into the Biotechnology Applications market in the Food & Beverage and Dietary Supplements sector.

This MindXchange saw a knowledge sharing of global and Indian trends, overview of the Indian market and opportunities, new developments, new technologies, regulations and challenges faced by this sector. Eminent speakers at the summit included - speaker from Avesthagen Ltd, Mr. Hemant Dande - Senior Vice President, Raptakos Brett & Co Ltd, Mr. Krishna Mohan Puvvada - Industry Sales Manager, Novozymes South Asia Pvt. Ltd., Dr J. Sambasiva Rao - Head Technical, Advanced Enzyme Technologies Ltd.,Dr. K.K Tripathi - Biosafety Advisor, Dept of Biotechnology, Ministry of Science and Technology, Dr. Smita Singhania, General Manager, Regulatory Affairs, Actis Biologics, Mr. Suhas Chaudhari - Joint Commissioner, FDA (Mumbai), and Mr. Isaac - Chairman and Managing Director, ABL Biotechnologies Ltd.

This event was partnered by Advanced Enzymes and supported by the Association of Biotechnology Led Enterprises. The media partners for the event were Beverage & Food World, Beverage & Food Processing, BioSpectrum, Times Food Processing Journal, Food & Beverage News, Express Pharma, Modern Food Processing, Processed Food Industry, and Kongposh Publications.

About Frost & Sullivan - "We Accelerate Growth"

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com

    Media contact:
    Anish Charles
    P: +91-22-4001-3419
    F: +91-22-2832-4713
    E: anish.charles@frost.com

    Caroline Lewis
    P: +91-98217-37935
    F: +91-22-2832-4713
    E: caroline.lewis@frost.com



'/>"/>
SOURCE Frost & Sullivan (India) Pvt. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
2. Neogen Named to Fortunes List of Fastest Growing Companies
3. Business Opportunities in Spains Fast-Growing Biotechnology Industry
4. ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand
5. CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
6. Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
7. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
8. Gore PharmBIO Products Opens New Facility with State-of-the-Art-Cleanroom Facility Built to Support Demand for Growing STA-PURE(TM) Product Line
9. GEN Reports on Growing Reliance on Microfluidics Technology
10. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
11. GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):